FINNENCE ▪ THE WIRE FILE
THE WIRE · № 91947
SEC Filing■ Mixed
META filed 4 on 2026-10-21
KINDSEC Filing
DIRECTION■ Mixed
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
THE MACHINE IS STILL READING THIS ITEM — ANALYSIS LANDS WITHIN MINUTES OF INGESTION.
FULL DISPATCH
META (CIK 0001564475) filed a 4 on 2026-10-21.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
SUBJECTMeta Platforms · META
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→INFERENCEfilings generate company commentary
New Phase 3 trial: Phase 2/3 Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older — GC Biopharma Corp2026-10-20 12:00 UTC
New Phase 3 trial: Phase 2/3 Clinical Trial to Evaluate the Immunogenicity and Safety of GC3114B in Adults Aged 65 Years or Older — GC Biopharma Corp2026-10-20 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Two-Part, Open-Label, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia — Waterstone Pharmaceutical (Wuhan) Co., LTD.2026-10-20 12:00 UTC
New Phase 3 trial: A Two-Part, Open-Label, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia — Waterstone Pharmaceutical (Wuhan) Co., LTD.2026-10-20 12:00 UTC
→INFERENCEfilings generate company commentary
Phase 3 results posted: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Janssen Research & Development, LLC2026-10-20 12:00 UTC
Phase 3 results posted: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Janssen Research & Development, LLC2026-10-20 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia — Wockhardt2026-10-21 12:00 UTC
New Phase 3 trial: Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia — Wockhardt2026-10-21 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults — Pfizer2026-10-21 12:00 UTC
New Phase 3 trial: A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults — Pfizer2026-10-21 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Trial to Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Standard of Care in Newly Diagnosed Multiple Myeloma — Gilead Sciences2026-10-21 12:00 UTC
New Phase 3 trial: A Trial to Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Standard of Care in Newly Diagnosed Multiple Myeloma — Gilead Sciences2026-10-21 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.